Table 2: Association between current ICS use and COVID-19 Death in ONS - Asthma Population
	N	Univariable		Age/Sex Adjusted		Age/Sex and Comorbidity Adjusted		
		HR	95% CI	HR	95% CI	HR	95% CI
Main Analysis
SABA only	49 (0.0)	1.00 (ref)		1.00 (ref)		1.00 (ref)
ICS (Low/Medium Dose)	362 (0.1)	1.32	0.98 - 1.77	0.98	0.73 - 1.33	1.10	0.82 - 1.49
ICS (High Dose)	104 (0.1)	2.28	1.62 - 3.20	1.59	1.14 - 2.24	1.52	1.08 - 2.14

